Egypt vs Guinea-Bissau: Previously treated cases tested for RR-/MDR-TB
Egypt
55.0%
in 2024
Guinea-Bissau
54.0%
in 2024
Egypt rank
145th
Guinea-Bissau rank
148th
Previously treated cases tested for RR-/MDR-TB over time
- Egypt
- Guinea-Bissau
How they compare
Egypt currently reports 55.0% against 54.0% in Guinea-Bissau, a difference of 1.0%.
The two have swapped places 4 times across 11 shared years of data; in 2013 it was Egypt ahead.
Egypt ranks 145th and Guinea-Bissau ranks 148th of 180 countries.
Egypt has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Egypt | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 80.1% | 53.6% | 26.6% | Egypt |
| 2020s | 73.0% | 62.2% | 10.8% | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Egypt or Guinea-Bissau?
- Egypt, at 55.0% against 54.0% in Guinea-Bissau as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Egypt and Guinea-Bissau?
- 1.0%, with Egypt ahead.
- How many years of comparable data are there for Egypt and Guinea-Bissau?
- 11 years are reported by both, from 2013 to 2024.
- How do Egypt and Guinea-Bissau rank globally for previously treated cases tested for rr-/mdr-tb?
- Egypt ranks 145th and Guinea-Bissau ranks 148th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.